Thrombospondin-1 suppresses wound healing and granulation tissue formation in the skin of transgenic mice

EMBO Journal

Volumn 19, Issue 13, 2000, Pages 3272-3282

  Streit, Michael ^a   Velasco, Paula ^a   Riccardi, Lucia ^a   Spencer, Lisa ^a   Brown, Lawrence F ^a   Janes, Lauren ^a   Lange Asschenfeldt, Bernhard ^a   Yano, Kiichiro ^a   Hawighorst, Thomas ^a   Iruela Arispe, Luisa ^b   Detmar, Michael ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Blood vessels; Skin; Transgenic mice; Wound healing

Indexed keywords

ANGIOGENESIS INHIBITOR; KERATIN; THROMBOSPONDIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL MIGRATION; CONTROLLED STUDY; FERTILITY; FIBROBLAST; GRANULATION TISSUE; HOMEOSTASIS; IN VITRO STUDY; IN VIVO STUDY; MICROVASCULATURE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN; SKIN BLOOD VESSEL; SKIN INJURY; TISSUE REPAIR; TRANSGENIC MOUSE; WOUND HEALING;

ANIMALIA; MUS MUSCULUS;

EID: 0034600837     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/19.13.3272     Document Type: Article

References (53)

1. Adams, J.C. (1997) Thrombospondin-1. Int. J. Biochem. Cell Biol., 29, 861-865.
2. Ando, Y. and Jensen, P. (1996) Protein kinase C mediates up-regulation of urokinase and its receptor in the migrating keratinocytes of wounded cultures, but urokinase is not required for movement across a substratum in vitro. J. Cell Physiol., 167, 500-511.
3. Arnold, F. and West, D.C. (1991) Angiogenesis in wound healing. Pharmacol. Ther., 52, 407-422.
4. Beer, H.-D., Longaker, M.T. and Werner, S. (1997) Reduced expression of PDGF and PDGF receptors during impaired wound healing. J. Invest. Dermatol., 109, 132-138.
5. Border, W.A. and Noble, N.A. (1994) Transforming growth factor β in tissue fibrosis. N. Engl. J. Med., 331, 1286-1292.
6. Bornstein, P. (1995) Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. J. Cell Biol., 130, 503-506.
7. Boukamp, P., Bleuel, K., Popp, S., Vormwald, D.V. and Fusenig, N. (1997) Functional evidence for tumor-suppressor activity on chromosome 15 in human skin carcinoma cells and thrombospondin-1 as the potential suppressor. J. Cell Physiol., 173, 256-260.
8. Brown, L.F., Yeo, K.T., Berse, B., Yeo, T.K., Senger, D.R., Dvorak, H.F. and Van De Water, L. (1992) Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J. Exp. Med., 176, 1375-1379.
9. Claffey, K.P., Brown, L.F., del Aguila, L.F., Tognazzi, K., Yeo, K.-T., Manseau, E.J. and Dvorak, H.F. (1996) Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis and experimental metastasis. Cancer Res., 56, 172-181.
10. Clark, R.A.F. (1993) Basics of cutaneous wound repair. J. Dermatol Surg. Oncol., 19, 693-706.
11. Dawson, D.W., Pearce, S.F., Zhong, R., Silverstein, R.L., Frazier, W.A. and Bouck, N.P. (1997) CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells. J. Cell Biol., 138, 707-717.
12. Detmar, M. (1996) Molecular regulation of angiogenesis in the skin. J. Invest. Dermatol., 106, 207-208.
13. Detmar, M., Yeo, K.-T., Nagy, J.A., Van De Water, L., Brown, L.F., Berse, B., Elicker, B.M., Ledbetter, S. and Dvorak, H.F. (1995) Keratinocyte-denved vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. J. Invest. Dermatol., 105, 44-50.
14. Detmar, M., Brown, L.F., Berse, B., Jackman, R.W., Elicker, B.M., Dvorak, H.F. and Claffey, K.P. (1997) Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin. J. Invest. Dermatol., 108, 263-268.
15. Detmar, M. et al. (1998) Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J. Invest. Dermatol., 111, 1-6.
16. Detmar, M., Velasco, P., Richard, L., Claffey, K.P., Streit, M., Riccardi.L., Skobe, M. and Brown, L.F. (2000) Expression of vascular endothelial growth Factor induces an invasive phenotype in human squamous cell carcinomas. Am. J. Pathol., 156, 159-167.
17. DiPietro, L.A., Nissen, N.N., Gamelli, R.L., Koch, A.E., Pyle, J.M. and Polverini, P.J. (1996) Thrombospondin 1 synthesis and function in wound repair. Am. J. PaihoL 148, 1851-1860.
18. Dvorak, H.F. (1986) Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med., 315, 1650-1659.
19. Frank, S., Huebner, G., Breier, G., Longaker, M.T., Greenhalgh, D.G. and Werner, S. (1995) Regulation of vascular endothelial growth factor expression in cultured keratinocytes: implications for normal and impaired wound healing. J. Biol. Chem., 270, 12607-12613.
20. Gross, J.P., Farinelli, W., Sadow, P., Anderson, R. and Bruns, R. (1995) On the mechanism of skin wound 'contraction': a granulation tissue 'knockout' with a normal phenotype. Proc. Natl Acad. Sci. USA, 92, 5982-5986.
21. Hennings, H., Michael, D., Cheng, C., Steinen, P., Holbrook, K. and Yuspa, S.H. (1980) Calcium regulation of growth and differentiation of mouse epidermal cells in culture. Cell, 19, 245-254.
22. Iruela-Arispe, M., Bornstein, P. and Sage, H. (1991) Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. Proc. Natl Acad. Sci. USA, 88, 5026-5030.
23. Kamimura, J., Lee, D., Baden, H.P., Brissette, J. and Dotto, G.P. (1997) Primary mouse keratinocyte cultures contain hair follicle progenitor cells with multiple differentiation potential. J. Invest. Dermatol., 109, 534-540.
24. Kyriakides, T.R. et al. (1998) Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesism, an increased vascular density and a bleeding diathesis. J. Cell Biol., 140, 419-430.
25. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685.
26. Martin, P. (1997) Wound healing - aiming for perfect skin regeneration. Science, 276, 75-81.
27. McClain, S.A., Simon, M., Jones, E., Nandi, A., Gailit, J.O., Tonnesen, M.G., New-man, D. and Clark, R.A.F. (1996) Mesenchymal cell activation is the rate-limiting step of granulation tissue induction. Am. J. Pathol., 149, 1257-1270.
28. Nicosia, R.F. and Tuszynski, G.P. (1994) Matrix-bound thrombospondin promotes angiogenesis in vitro. J. Cell Biol., 124, 183-193.
29. O'Reilly, M.S. et al. (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell, 79, 315-328.
30. O'Reilly, M.S. et al. (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 88, 277-285.
31. Ortega, S., Ittmann, M., Tsang, S.H., Ehrlich, M. and Basilico, C. (1998) Neuronal detects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc. Natl Acad. Sci. USA, 95, 5672-5677.
32. Phan, S.H., Dillon, R.G., McGarry, B.M. and Dixit, V.M. (1989) Stimulation of fibroblast proliferation by thrombospondin. Biochem. Biophys. Res. Commun., 163, 56-63.
33. Pike, S.E. et al. (1998) Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth. J. Exp. Med., 188, 2349-2356.
34. Polverini, P.J., DiPietro, L.A., Dixit, V.M., Hynes, R.O. and Lawler, J. (1995) Thrombospondin 1 knock out mice show delayed organization and prolonged neovascularization of skin wounds. FASEB J., 9, A272.
35. Raugi, G.J., Olerud, J.E. and Gown, A.M. (1987) Thrombospondin in early human wound tissue. J. Invest. Dermatol., 89, 551-554.
36. Reed, M.J., Puolakkainen, P., Lane, T.F., Dickerson, D., Bornstein, P. and Sage, E.H. (1993) Differential expression of SPARC and thrombospondin 1 in wound repair: immunolocalization and in situ hybridisation. J. Histochem. Cytochem., 41, 1467-1477.
37. Richard, L., Velasco, P. and Detmar, M. (1998) A simple immunomagnetic protocol for the selective isolation and long-term culture of human dermal microvascular endothelial cells. Exp. Cell Res., 240, 1-6.
38. Roth, J.J., Albo, D., Rothman, V.L., Longaker, M.T., Granick, M.S., Long, C.D., Solomon, M.P. and Tuszynski, G.P. (1998) Thrombospondin-1 and its CSVTCG-specific receptor in wound healing and cancer. Ann. Plast. Surg., 40, 494-501.
39. 3 integrin. osteopontin and thrombin. Am. J. Pathol., 149, 293-305.
40. Skobe, M., Rockwell, P., Goldstein, N., Vosseler, S. and Fusenig, N.E. (1997) Halting angiogenesis suppresses carcinoma cell invasion. Nature Med., 3, 1222-1227.
41. Stadelmann, W.K., Digenis, A.G. and Tobin, G.R. (1998) Physiology and healing dynamics of chronic cutaneous wounds. Am. J. Surg., 176, 26-38.
42. Streit, M., Velasco, P., Brown, L.F., Skobe, M., Richard, L., Riccardi, L., Lawler, J. and Detmar, M. (1999a) Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas. Am. J. Pathol., 155, 441-452.
43. Streit, M., Riccardi, L., Velasco, P., Brown, L.F., Hawighorst, T., Bornstein, P. and Detmar, M. (1999b) Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis. Proc. Natl Acad. Sci. USA, 96, 14888-14893.
44. Thurston, G., Baluk, P., Hirata, A. and McDonald, D.M. (1996) Permeability-related changes revealed at endothelial cell borders in inflamed venules by lectin binding. Am. J. Physiol., 271, H2547-2562.
45. Thurston, G., Murphy, T.J., Baluk, P., Lindsey, J.R. and McDonald, D.M. (1998) Angiogenesis in mice with chronic airway inflammation: strain-dependent differences. Am. J. Pathol., 153, 1099-1112.
46. Tolsma, S.S., Volpert, O.V., Good, D.J., Frazier, W.A., Polverini, P.J. and Bouck, N. (1993) Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J. Cell Biol., 122, 497-511.
47. Vassar, R., Rosenberg, M., Ross, S., Tyner, A. and Fuchs, E. (1989) Tissue-specific and differentiation-specific expression of a human K14 keratin gene in transgenic mice. Proc. Natl Acad. Sci. USA, 86, 1563-1567.
48. Volpert, O.V., Tolsma, S.S., Pellerin, S., Feige, J.J., Chen, H., Mosher, D.F. and Bouck, N. (1995) Inhibition of angiogenesis by thrombospondin-2. Biochem. Biophys. Res. Commun., 217, 326-332.
49. Werner, S., Peters, K.G., Longaker, M.T., Fuller, P.F., Banda, M.J. and Williams, L.T. (1992) Large induction of keratinocyte growth factor expression in the dermis during wound healing. Proc. Natl Acad. Sci. USA, 89, 6896-6900.
50. Werner, S., Smola, H., Liao, X., Longaker, M.T., Krieg, T., Hofschneider, P.H. and Williams, L.T. (1994) The function of KGF in morphogenesis of epithelium and re-epithelialization of wounds. Science, 266, 819-822.
51. Wight, T.N., Raugi, G.J., Mumby, S.M. and Bornstein, P. (1985) Light microscopic immunolocation of thrombospondin in human tissues. J. Histochem. Cytochem., 33, 295-302.
52. Yehualaeshet, T., O'Connor, R., Green, J.J., Mai, S., Silverstein, R., Murphy, U.J. and Khalil, N. (1999) Activation of rat alveolar macrophage-derived latent transforming growth factor β-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor. CD36. Am. J. Pathol., 155, 841-851.
53. Yuan, F., Chen, Y., Dellian, M., Safabakhsh, N., Ferrara, N. and Jain, R.K. (1996) Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc. Natl Acad. Sci. USA, 93, 14765-14770.